The failure of glycopeptide antibiotics led to the creation of a new class of drug, the streptogramins, a combination of quinipristin and dalfopristin.
Glycopeptide antibiotics: From conventional molecules to new derivatives.
The relevant markets in which overlaps occurred were found to be for vitamin B12 in France, positive inotropic agents in the United Kingdom and Belgium, cerebral and peripheral vasotherapeutics in Ireland, topical varicose therapy in Italy, macrolides and similar types in France,
glycopeptide antibiotics also in France, specific anti-rheumatics in Portugal, muscle relaxants also in Portugal, hypnotics and sedatives in Greece, Ireland, Luxembourg and Sweden, heparins and heparinoids in Germany, Austria, Belgium, Spain, Finland, France, Italy, Luxembourg, the Netherlands, Portugal and the United Kingdom, and treatment of colorectal cancer in France, Germany, Italy, the Netherlands, Spain, Sweden and the United Kingdom.